IMP
Process View
response to amino acid
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to amino acid"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.948 | Mouse | |
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.925 | ||
| LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 0.787 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.787 | ||
| TOB1 | transducer of ERBB2, 1 | 0.764 | ||
| RRAGC | Ras-related GTP binding C | 0.709 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.627 | Mouse | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.562 | Rat | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.552 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.536 | ||
| GARS | glycyl-tRNA synthetase | 0.477 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.418 | Mouse | |
| IARS | isoleucyl-tRNA synthetase | 0.414 | ||
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.401 | ||
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.387 | ||
| GSTM2 | glutathione S-transferase mu 2 (muscle) | 0.295 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.255 | Mouse | |
| ACTG1 | actin, gamma 1 | 0.236 | ||
| BCL2L1 | BCL2-like 1 | 0.213 | Mouse | |
| COL1A2 | collagen, type I, alpha 2 | 0.195 | Mouse | |
| ASNS | asparagine synthetase (glutamine-hydrolyzing) | 0.187 | Rat | |
| GSK3B | glycogen synthase kinase 3 beta | 0.184 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.184 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.181 | ||
| LAMTOR2 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 | 0.124 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.119 | ||
| ESRRG | estrogen-related receptor gamma | 0.110 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.108 | ||
| DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 0.094 | Mouse | |
| NRP1 | neuropilin 1 | 0.092 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.089 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.081 | Mouse | |
| RRAGD | Ras-related GTP binding D | 0.080 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.079 | ||
| MARS | methionyl-tRNA synthetase | 0.077 | ||
| EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 0.071 | ||
| MAPT | microtubule-associated protein tau | 0.070 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.069 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.063 | ||
| BECN1 | beclin 1, autophagy related | 0.060 | ||
| AARS | alanyl-tRNA synthetase | 0.059 | Mouse | |
| LAMTOR3 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 | 0.057 | ||
| EED | embryonic ectoderm development | 0.057 | ||
| GSTM4 | glutathione S-transferase mu 4 | 0.057 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.054 | Rat | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.051 | ||
| AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.044 | ||
| THBS1 | thrombospondin 1 | 0.043 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.042 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.042 | ||
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.041 | Mouse | |
| AGTR2 | angiotensin II receptor, type 2 | 0.040 | ||
| SARS | seryl-tRNA synthetase | 0.040 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.039 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.037 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.036 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.035 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.035 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.034 | ||
| FBN1 | fibrillin 1 | 0.034 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.033 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.032 | ||
| PRDX1 | peroxiredoxin 1 | 0.031 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.031 | ||
| EPRS | glutamyl-prolyl-tRNA synthetase | 0.028 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.027 | ||
| CAPNS1 | calpain, small subunit 1 | 0.026 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.026 | ||
| YARS | tyrosyl-tRNA synthetase | 0.025 | ||
| CARS | cysteinyl-tRNA synthetase | 0.025 | ||
| DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 0.022 | ||
| TFRC | transferrin receptor (p90, CD71) | 0.021 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.021 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.021 | ||
| FERMT2 | fermitin family member 2 | 0.021 | ||
| C7orf59 | chromosome 7 open reading frame 59 | 0.020 | ||
| GSTM3 | glutathione S-transferase mu 3 (brain) | 0.020 | ||
| SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) | 0.019 | ||
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.019 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.019 | Mouse | |
| HBXIP | hepatitis B virus x interacting protein | 0.018 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.018 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.017 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.017 | ||
| FN1 | fibronectin 1 | 0.017 | ||
| JAK2 | Janus kinase 2 | 0.017 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.017 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.016 | ||
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.016 | ||
| CFL2 | cofilin 2 (muscle) | 0.016 | ||
| DCN | decorin | 0.015 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.015 | ||
| PTEN | phosphatase and tensin homolog | 0.015 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.015 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.015 | ||
| LOX | lysyl oxidase | 0.015 | ||
| CDCP1 | CUB domain containing protein 1 | 0.014 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.014 | Mouse | |
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.013 | ||
| DEPTOR | DEP domain containing MTOR-interacting protein | 0.013 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.013 | ||
| KIF1B | kinesin family member 1B | 0.013 | ||
| HDAC1 | histone deacetylase 1 | 0.012 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.012 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.012 | ||
| UBE2A | ubiquitin-conjugating enzyme E2A (RAD6 homolog) | 0.012 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.012 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.011 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.011 | ||
| ATG14 | ATG14 autophagy related 14 homolog (S. cerevisiae) | 0.011 | ||
| CTBP1 | C-terminal binding protein 1 | 0.011 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.011 | ||
| EZH2 | enhancer of zeste homolog 2 (Drosophila) | 0.011 | ||
| TARS | threonyl-tRNA synthetase | 0.011 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.010 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.010 |